Immune Cell‐Mediated Retinoblastoma Development: Genetic and Molecular Mechanisms
International Journal of Genomics · 2026-01 · 2026 (1)
DOI: 10.1155/ijog/6303747 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Genomics, online erschienen am 09.04.2026. Verfasst von Xinyang Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China, ahmu.edu.cn. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Provincial Key Research and Development Plan, Natural Science Foundation of Tibet Autonomous Region.
Abstract (Originalsprache)
Retinoblastoma (RB) is the most prevalent malignant tumor that originates within the eye in children, occurring at a frequency of around 1:20,000 to 1:15,000. RB typically occurs when both alleles of the retinoblastoma 1 (RB1) gene are deactivated. RB is associated with variations in the tumor suppressor gene RB1 and is inherited in an autosomal recessive manner, operating at the genetic level. Variation in RB1 occurs only when two alleles of the RB1 gene are mutated. The mechanism by which immune cells mediate RB1 to affect RB is still unclear. Using two‐sample Mendelian randomization (MR) analysis based on published genome‐wide association study (GWAS) summary statistics, we investigated the relationship between immune cells and RB1 proteins. Our goal was to understand their potential role in the development of RB in offspring. The analysis of alterations in RB tissue cells and potential molecular mechanisms was conducted using single‐cell RNA sequencing data. The research revealed the presence of 28 immune cells linked with RB1. These variables might potentially impact the likelihood of RB in children by altering the expression of the RB1 gene in their parents. Furthermore, we found differential gene expression in different cells of the RB tissue. EZH2, UBLCP1, and HKDC1 overlapped with the identified instrumental variables (IVs) of immune cells to investigate potential molecular mechanisms by which immune cells participate in RB processes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China, ahmu.edu.cn.
- The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China, ahmu.edu.cn.
- School of Public Health of Anhui Medical University, Hefei, 230032, China.
- Department of Ophthalmology, Shannan City People's Hospital, Shannan, 856100, China.
- Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China, ahmu.edu.cn.
ORCID-Profile: Xinyang Hu, Jingqiu Li, Jinhong Li, Wenxuan Chen, Haibo Zhang, Dan Li, Ming Zhu, Liang Pang, Siqi Fan, Suolang Yangzong, Ciren Deji, Dongwei Liu
Förderung
- Anhui Provincial Key Research and Development Plan
- Natural Science Foundation of Tibet Autonomous Region
Zitieren
APA
Hu, X., Li, J., Li, J., Chen, W., Zhang, H., Li, D., Zhu, M., Pang, L., Fan, S., Yangzong, S., Deji, C., & Liu, D. (2026). Immune Cell‐Mediated Retinoblastoma Development: Genetic and Molecular Mechanisms. International Journal of Genomics, 2026(1). https://doi.org/10.1155/ijog/6303747
Vancouver
Hu X, Li J, Li J, Chen W, Zhang H, Li D, et al. Immune Cell‐Mediated Retinoblastoma Development: Genetic and Molecular Mechanisms. International Journal of Genomics. 2026;2026(1). doi:10.1155/ijog/6303747
BibTeX
@article{Hu2026,
author = {Hu, Xinyang and Li, Jingqiu and Li, Jinhong and Chen, Wenxuan and Zhang, Haibo and Li, Dan and Zhu, Ming and Pang, Liang and Fan, Siqi and Yangzong, Suolang and Deji, Ciren and Liu, Dongwei},
title = {Immune Cell‐Mediated Retinoblastoma Development: Genetic and Molecular Mechanisms},
journal = {International Journal of Genomics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijog/6303747}
}
EUVIMED